Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address the state of the market and healthcare innovation at the March 16-17 premier Utah life sciences event.
Salt Lake City, Utah - January 23 - BioUtah, Utah’s trade association dedicated to the life sciences, in partnership with the University of Utah’s Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center and BioHive today announced its preliminary agenda and distinguished keynote speaker, J.P. Morgan’s Monica DiCenso, for the 2023 Entrepreneur & Investor Life Sciences Summit (E&I Summit) to be held March 16-17. Ms. DiCenso is the managing director and head of Global Investment Opportunities Group at J.P. Morgan Private Bank. This year’s summit is sponsored by Wilson Sonsini.
“Ms. DiCenso’s expertise on market dynamics, particularly in this time of economic uncertainty, will help set the stage for the two-day E&I Summit and shed light on the investment environment and outlook for the life sciences,” said Keith Marmer, chief innovation and economic engagement officer for the University of Utah.
For more information and to register visit www.eilifesciencessummit.org.
Also taking center stage will be top-tier CEOs of innovative Utah life sciences companies, including Dan Lemaitre of Bluewind Medical and David Bearss of Halia Therapeutics. These executives and others will share their well-honed perspectives on building a life sciences company.
Principals from national venture capital firms as well as leaders of Utah’s local investment community will discuss what it takes for early-stage companies to attract capital. A dedicated networking session will provide attendees an opportunity to make valuable contacts. The E&I Summit will once again hold its popular Pitch Competition with six companies selected to pitch their product before a slate of seasoned judges. Information on all applicant companies will be available on the E&I website.
“Summit-goers will be able to hear some of the best and brightest in our industry,” said Kelvyn Cullimore, president and CEO of BioUtah. “Whether your focus is medical devices, diagnostics or therapeutics, the E&I Summit is designed to showcase all segments of our industry and to connect entrepreneurs with the larger investment community.”
About BioUtah
BioUtah is an independent 501(c)(6) trade association serving Utah’s life sciences industry. Its member companies reflect a broad spectrum of the industry with strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and advanced diagnostics, amongst others; and are a key driver of Utah’s economy. BioHive is a chartered organization of BioUtah. Its mission is to brand, build and bring together Utah’s life sciences and healthcare innovation community through affinity group activities, community service and promotion of STEM education.
About the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center
The Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center leads the University of Utah’s centralized and integrated strategy and operation for technology commercialization, corporate engagement and economic development. In doing so, the center serves as a hub for the U to foster partnerships between industry, university and government entities. The center formalizes the U’s commitment to broaden its impact on Utah’s economy by enhancing local and global collaborations to catalyze innovation. Dedicated to helping the University of Utah’s faculty inventors bring their innovations to market, PIVOT Center is responsible for all aspects of invention management, patent prosecution, licensing, startup formation and support, equity management and early stage funding. The University of Utah was recently ranked 2nd among large research universities for “innovation productivity impact.”